104 related articles for article (PubMed ID: 2443562)
1. Evidence that expression of asialo-GM1 may be associated with cell activation. Correlation of asialo-GM1 expression with increased total cellular RNA and protein content in normal thymocyte and spleen cell populations.
Stout RD; Schwarting GA; Suttles J
J Immunol; 1987 Oct; 139(7):2123-9. PubMed ID: 2443562
[TBL] [Abstract][Full Text] [Related]
2. Expression of asialo GM1 on a subset of adult murine thymocytes: histological localization and demonstration that the asialo GM1-positive subset contains both the functionally mature and the proliferating thymocyte subpopulations.
Suttles J; Schwarting GA; Hougland MW; Stout RD
J Immunol; 1987 Jan; 138(2):364-72. PubMed ID: 3098839
[TBL] [Abstract][Full Text] [Related]
3. Expression of asialo GM1 and other antigens and glycolipids on natural killer cells and spleen leukocytes in virus-infected mice.
Yang H; Yogeeswaran G; Bukowski JF; Welsh RM
Nat Immun Cell Growth Regul; 1985; 4(1):21-39. PubMed ID: 3875791
[TBL] [Abstract][Full Text] [Related]
4. Expression of asialo GM1 by both Thy-1-positive and Thy-1-negative lymphocytes: evidence for modification of asialo GM1 by sialic acid.
Harris MT; Schwarting GA; Stout RD
Thymus; 1981 Sep; 3(3):169-84. PubMed ID: 6171919
[TBL] [Abstract][Full Text] [Related]
5. Selective expression of asialo GM1 on maturational subsets of lymphocytes in normal and athymic mice.
Harris MT; Schwarting GA; Stout RD
Thymus; 1981 Sep; 3(3):153-67. PubMed ID: 6171918
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric analysis reveals the presence of asialo GM1 on the surface membrane of alloimmune cytotoxic T lymphocytes.
Suttles J; Schwarting GA; Stout RD
J Immunol; 1986 Mar; 136(5):1586-91. PubMed ID: 2936802
[TBL] [Abstract][Full Text] [Related]
7. Glycolipids of murine lymphocyte subpopulations: a defect in the levels of sialidase-sensitive sialosylated asialo GM1 in beige mouse lymphocytes.
Schwarting GA; Gajewski A
J Immunol; 1981 Jun; 126(6):2403-7. PubMed ID: 6971898
[TBL] [Abstract][Full Text] [Related]
8. A phenyl-beta-galactoside-specific monoclonal antibody reactive with murine and rat NK cells.
Miller VE; Lagarde AE; Longenecker BM; Greenberg AH
J Immunol; 1986 Apr; 136(8):2968-74. PubMed ID: 2420880
[TBL] [Abstract][Full Text] [Related]
9. The role of anti-asialo GM1 antibody-sensitive cells in the implementation of tumor-specific T cell-mediated immunity in vivo.
Yoshioka T; Sato S; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1986 Aug; 77(8):825-32. PubMed ID: 3093429
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
Kalland T; Belfrage H; Bhiladvala P; Hedlund G
J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
[TBL] [Abstract][Full Text] [Related]
11. The control of IL-4 gene expression in activated murine T lymphocytes: a novel role for neu-1 sialidase.
Chen XP; Enioutina EY; Daynes RA
J Immunol; 1997 Apr; 158(7):3070-80. PubMed ID: 9120259
[TBL] [Abstract][Full Text] [Related]
12. Purification and target cell range of in vivo elicited blast natural killer cells.
Biron CA; Pedersen KF; Welsh RM
J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814
[TBL] [Abstract][Full Text] [Related]
13. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T
Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715
[TBL] [Abstract][Full Text] [Related]
14. Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities.
Stitz L; Baenziger J; Pircher H; Hengartner H; Zinkernagel RM
J Immunol; 1986 Jun; 136(12):4674-80. PubMed ID: 3486908
[TBL] [Abstract][Full Text] [Related]
15. The effect of various cytokines on the in vitro induction of antibody-dependent cellular cytotoxicity in murine cells. Enhancement of IL-2-induced antibody-dependent cellular cytotoxicity activity by IL-1 and tumor necrosis factor-alpha.
Eisenthal A; Rosenberg SA
J Immunol; 1989 Apr; 142(7):2307-13. PubMed ID: 2647849
[TBL] [Abstract][Full Text] [Related]
16. In vivo requirement for asialo GM1 and Thy1 positive leukocytes for antitumor effect of rIL-2 +/- rIFN-gamma.
Silagi S; Dutkowski R; Schaefer A
Anticancer Res; 1988; 8(6):1265-9. PubMed ID: 2905882
[TBL] [Abstract][Full Text] [Related]
17. Murine lymphokine-activated killer (LAK) cells: phenotypic characterization of the precursor and effector cells.
Yang JC; Mulé JJ; Rosenberg SA
J Immunol; 1986 Jul; 137(2):715-22. PubMed ID: 2873187
[TBL] [Abstract][Full Text] [Related]
18. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
Vujanovic NL; Herberman RB; Olszowy MW; Cramer DV; Salup RR; Reynolds CW; Hiserodt JC
Cancer Res; 1988 Feb; 48(4):884-90. PubMed ID: 3257412
[TBL] [Abstract][Full Text] [Related]
19. IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes.
Peace DJ; Kern DE; Schultz KR; Greenberg PD; Cheever MA
J Immunol; 1988 May; 140(10):3679-85. PubMed ID: 2896213
[TBL] [Abstract][Full Text] [Related]
20. Asialo-GM1-positive T killer cells are generated in F1 mice injected with parental spleen cells.
Knobloch C; Dennert G
J Immunol; 1988 Feb; 140(3):744-9. PubMed ID: 2448375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]